Total Funding
$253.9M
Employee Range
11-50
iOnctura is a biopharmaceutical company dedicated to developing innovative therapies that target the key factors contributing to immunosuppression within the tumor microenvironment. By addressing the limitations of existing immune checkpoint inhibitors, iOnctura aims to enhance treatment effectiveness for a broader range of cancer patients.
iOnctura data powered by:
Share
iOnctura data powered by:
iOncturaOverall Ranking
Regional Rank
Share
Loading...
In Western Europe
Top null%out of exits
iOncturaIndustry Rankings in
HealthtechRegional Rank
Share
Loading...
In Western Europe
Top null%out of 57 exits
iOncturaSubindustry Rankings in
BiotechnologyRegional Rank
Share
Loading...
In Western Europe
Top null%out of 42 exits
rankings by:
iOncturaSB Rank Evolution
Not enough data points to display the chart.
iOncturaexitComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro